Truist downgraded Merck (MRK) to Hold from Buy with a price target of $110, down from $130, as part of a broader research note previewing FY25 for large-cap biopharma. The sector has ...

Truist Financial analyst Srikripa Devarakonda downgraded Merck & Company (MRK – Research Report) to a Hold yesterday and set a price target of $110.00. The company’s shares closed yesterday at ...

Een fusie met Honda wordt overwogen en mogelijk komt er nog een derde merk bij, om nog sterker te staan. Als een merk dreigt om te vallen, ontstaat natuurlijk het risico van een snellere daling ...

Merk Snack Bar owner Mark Baker announced on social media in late December that he would be closing the Ottawa Street North eatery at the end of January.

Viking Therapeutics (NASDAQ:VKTX) and Structure Therapeutics (NASDAQ:GPCR) were among notable decliners on Wednesday after Merck (NYSE:MRK) partnered with Chinese biopharma Hansoh (OTCPK ...

BEIJING, Jan 8 (Reuters) - Merck's (MRK.N), opens new tab human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in ...

Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is expected to be finalized by the end of 2024, according to a Dec ...

China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the US drug giant after a rush among women to get the shot lost steam.

Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024, despite challenges with other products. Promising future developments include ...

Dec 23 (Reuters) - Merck (MRK.N), opens new tab will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

Merck just closed a deal to develop a weight-loss drug. The market appears to think Viking Therapeutics is threatened by that data. There's little reason to write off Viking here. First, let's get ...